Dravet syndrome Trials in San Francisco, United States
Conditions / Dravet syndrome / San Francisco, United States
Research into Dravet syndrome spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02823145 | An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 |
| NCT02682927 | A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome | COMPLETED | PHASE3 |
| NCT04462770 | A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome | RECRUITING | PHASE3 |
| NCT03936777 | A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome | COMPLETED | PHASE3 |
| NCT04740476 | An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04442295 | An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome | COMPLETED | PHASE1/PHASE2 |
| NCT06660394 | A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) | RECRUITING | — |
| NCT05364021 | Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies | COMPLETED | PHASE1/PHASE2 |
| NCT05626634 | Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy | COMPLETED | PHASE2 |
| NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | RECRUITING | PHASE3 |